发明授权
- 专利标题： TACI-immunoglobulin fusion proteins
- 专利标题（中）： TACI-免疫球蛋白融合蛋白
-
申请号： US11242294申请日： 2005-10-03
-
公开(公告)号： US07501497B2公开(公告)日： 2009-03-10
- 发明人: Mark W. Rixon , Jane A. Gross
- 申请人： Mark W. Rixon , Jane A. Gross
- 申请人地址： US WA Seattle
- 专利权人： ZymoGenetics, Inc.
- 当前专利权人： ZymoGenetics, Inc.
- 当前专利权人地址： US WA Seattle
- 代理商 Michelle L. Lewis
- 主分类号： C12P21/08
- IPC分类号： C12P21/08 ; C07K16/00 ; A61K39/395 ; C12P21/04
摘要：
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
公开/授权文献
- US20060034852A1 TACI-immunoglobulin fusion proteins 公开/授权日：2006-02-16